{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:36:22Z","timestamp":1791344182096,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ghir.2024.101625","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T17:24:09Z","timestamp":1728494649000},"page":"101625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular disease"],"prefix":"10.1016","volume":"79","author":[{"given":"Cheryl A.","family":"Conover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ghir.2024.101625_bb0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0304-4165(94)90071-X","article-title":"Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein","volume":"1201","author":"Oxvig","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.ghir.2024.101625_bb0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tem.2012.02.008","article-title":"Key questions and answers about pregnancy-associated plasma protein-A","volume":"23","author":"Conover","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2024.101625_bb0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2796.1997.00197.x","article-title":"The emergence of mouse models of atherosclerosis and their relevance to clinical research","volume":"242","author":"Smith","year":"1997","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ghir.2024.101625_bb0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2024.101625_bb0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ghir.2024.101625_bb0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.ATV.14.1.141","article-title":"Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression","volume":"14","author":"Reddick","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.ghir.2024.101625_bb0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.atherosclerosis.2018.10.004","article-title":"Pregnancy-associated plasma protein-A in atherosclerosis: molecular marker, mechanistic insight, and therapeutic target","volume":"278","author":"Yu","year":"2018","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.ghir.2024.101625_bb0040","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/CIRCRESAHA.106.146183","article-title":"Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet","volume":"100","author":"Harrington","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2024.101625_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbrc.2020.09.132","article-title":"Suppression of PAPP-A mitigates atherosclerosis by mediating macrophage polarization via STAT3 signaling","volume":"543","author":"Wang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.ghir.2024.101625_bb0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1253\/circj.CJ-18-0700","article-title":"Pregnancy-associated plasma protein-A accelerates atherosclerosis by regulating reverse cholesterol transport and inflammation","volume":"83","author":"Tang","year":"2019","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.ghir.2024.101625_bb0055","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1038\/s41467-022-33698-8","article-title":"Structure of the proteolytic enzyme PAPP-A with the endogenous inhibitor stanniocalcin-2 reveals its inhibitory mechanism","volume":"13","author":"Kobber\u00f8","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ghir.2024.101625_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2016.02.026","article-title":"Stanniocalcin-2 overexpression reduces atherosclerosis in hypercholesterolemic mice","volume":"248","author":"Steffensen","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ghir.2024.101625_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12265-015-9666-9","article-title":"Targeted inhibition of pregnancy-associated plasma protein-A activity reduces atherosclerotic plaque burden in mice","volume":"9","author":"Conover","year":"2016","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"2","key":"10.1016\/j.ghir.2024.101625_bb0070","doi-asserted-by":"crossref","first-page":"H284","DOI":"10.1152\/ajpheart.00904.2009","article-title":"Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development","volume":"299","author":"Conover","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.ghir.2024.101625_bb0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1210\/en.2012-1552","article-title":"Effects of mutated pregnancy-associated plasma protein-A on atherosclerotic lesion development in mice","volume":"154","author":"Boldt","year":"2013","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ghir.2024.101625_bb0080","first-page":"1","article-title":"Effect of pregnancy associated plasma protein-A overexpression on atherosclerotic plaque morphology in mice","volume":"2","author":"Conover","year":"2014","journal-title":"J. Cardio. Vasc. Med."},{"issue":"12","key":"10.1016\/j.ghir.2024.101625_bb0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/en.2006-0493","article-title":"Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury","volume":"147","author":"Resch","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2024.101625_bb0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.ATV.21.3.335","article-title":"Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increase in the coronary artery after angioplasty","volume":"21","author":"Bayes-Genis","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"14","key":"10.1016\/j.ghir.2024.101625_bb0095","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa003147","article-title":"Pregnancy-associated plasma protein A as a marker of acute coronary syndromes","volume":"345","author":"Bayes-Genis","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ghir.2024.101625_bb0100","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jacc.2005.11.086","article-title":"Pregnancy-associated plasma protein-A is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events","volume":"47","author":"Sangiorgi","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ghir.2024.101625_bb0105","doi-asserted-by":"crossref","first-page":"H994","DOI":"10.1152\/ajpheart.00798.2006","article-title":"Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages","volume":"292","author":"Conover","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.ghir.2024.101625_bb0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.clinbiochem.2010.12.010","article-title":"Pregnancy associated plasma protein-A (PAPP-A) is not a marker of the vulnerable atherosclerotic plaque","volume":"44","author":"Iversen","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ghir.2024.101625_bb0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12872-015-0041-1","article-title":"Correlation of single nucleotide polymorphisms in the pregnancy-associated plasma protein-A gene with carotid plaques","volume":"15","author":"Zhou","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ghir.2024.101625_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.athplu.2024.09.001","article-title":"The pro-atherogenic enzyme PAPP-A is active in eluates from human carotid and femoral atherosclerotic plaques","volume":"57","author":"Gude","year":"2024","journal-title":"Atheroscleros. Plus."},{"issue":"1","key":"10.1016\/j.ghir.2024.101625_bb0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.amjcard.2007.07.045","article-title":"Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy","volume":"101","author":"Miedema","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ghir.2024.101625_bb0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.atherosclerosis.2008.07.042","article-title":"Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk","volume":"203","author":"Consuegra-Sanchez","year":"2009","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ghir.2024.101625_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1573403X18666220411113450","article-title":"Synopsis of biomarkers of atheromatous plaque formation, rupture and thrombosis in the diagnosis of acute coronary syndromes","volume":"18","author":"Udaya","year":"2022","journal-title":"Curr. Cardiol. Rev."},{"issue":"8","key":"10.1016\/j.ghir.2024.101625_bb0140","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2217\/bmm.14.53","article-title":"Pregnancy-associated plasma protein-A and the vulnerable plaque","volume":"8","author":"Jespersen","year":"2014","journal-title":"Biomark. Med"},{"issue":"3\u20134","key":"10.1016\/j.ghir.2024.101625_bb0145","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cca.2010.11.024","article-title":"Studies on the effects of heparin products on pregnancy-associated plasma protein A","volume":"412","author":"Wittfooth","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"7\u20138","key":"10.1016\/j.ghir.2024.101625_bb0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clinbiochem.2011.12.030","article-title":"N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia","volume":"45","author":"Postnikov","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ghir.2024.101625_bb0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinbiochem.2014.11.022","article-title":"PAPP-A and IGFBP-4 fragment levels in patients with ST-elevation myocardial infarction treated with heparin and PCI","volume":"48","author":"Hjortebjerg","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ghir.2024.101625_bb0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clinbiochem.2018.03.004","article-title":"Glycosylated and non-glycosylated NT-IGFBP-4 in circulation of acute coronary syndrome patients","volume":"55","author":"Konev","year":"2018","journal-title":"Clin. Biochem."},{"issue":"11","key":"10.1016\/j.ghir.2024.101625_bb0165","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa617","article-title":"Local IGF bioactivity associates with high PAPP-A activity in the pericardial cavity of cardiovascular disease patients","volume":"105","author":"Hjortebjerg","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2024.101625_bb0170","article-title":"Cellular characterization of human epicardial adipose tissue: highly expressed PAPP-A regulates insulin-like growth factor I signaling in human cardiomyocytes","volume":"7","author":"Conover","year":"2019","journal-title":"Phys. Rep."},{"issue":"7","key":"10.1016\/j.ghir.2024.101625_bb0175","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/cvr\/cvy055","article-title":"Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A","volume":"114","author":"Barile","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.ghir.2024.101625_bb0180","first-page":"C183","article-title":"Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol","volume":"290","author":"Conover","year":"2006","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"3","key":"10.1016\/j.ghir.2024.101625_bb0185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ghir.2007.09.001","article-title":"Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells","volume":"18","author":"Conover","year":"2008","journal-title":"Growth Hormon. IGF Res."},{"issue":"11","key":"10.1016\/j.ghir.2024.101625_bb0190","first-page":"14401","article-title":"MicroRNA-141 inhibits vascular smooth muscle cell proliferation through targeting PAPP-A","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.ghir.2024.101625_bb0195","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cvr\/cvt172","article-title":"MiR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-A","volume":"100","author":"Sun","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.ghir.2024.101625_bb0200","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cvr\/cvz203","article-title":"Non-coding RNAs in cardiovascular cell biology and atherosclerosis","volume":"115","author":"Fasolo","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ghir.2024.101625_bb0205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-pathol-012615-044135","article-title":"Mechanisms of MicroRNAs in atherosclerosis","volume":"11","author":"Schober","year":"2016","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"10.1016\/j.ghir.2024.101625_bb0210","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/FJC.0000000000000959","article-title":"Knockdown of H19 attenuates ox-LDL-induced vascular smooth muscle cell proliferation, migration, and invasion by regulating miR-599\/PAPPA Axis","volume":"77","author":"Lu","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.ghir.2024.101625_bb0215","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1677\/joe.1.06259","article-title":"Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A","volume":"186","author":"Bale","year":"2005","journal-title":"J. Endocrinol."},{"issue":"12","key":"10.1016\/j.ghir.2024.101625_bb0220","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1253\/circj.CJ-20-0345","article-title":"Hsa-circ_0010283 regulates oxidized low-density lipoprotein-induced proliferation and migration of vascular smooth muscle cells by targeting the miR-133a-3p\/pregnancy-associated plasma protein A Axis","volume":"84","author":"Feng","year":"2020","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.ghir.2024.101625_bb0225","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3233\/CH-211288","article-title":"Circ-CHFR modulates the proliferation, migration, and invasion of ox-LDL-induced human aorta vascular smooth muscle cells through the miR-214-3p\/PAPPA axis","volume":"80","author":"Lu","year":"2022","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"1\u20132","key":"10.1016\/j.ghir.2024.101625_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11010-020-03764-0","article-title":"Circular RNA circ_0124644 exacerbates the ox-LDL-induced endothelial injury in human vascular endothelial cells through regulating PAPP-A by acting as a sponge of miR-149-5p","volume":"471","author":"Wang","year":"2020","journal-title":"Mol. Cell. Biochem."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637424000558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637424000558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T07:55:24Z","timestamp":1731657324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637424000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"alternative-id":["S1096637424000558"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2024.101625","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2024.101625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101625"}}